Aytu BioPharma, Inc. (AYTU) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Aytu BioPharma, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -1.01x | -1.00x | -0.31x | -0.19x | -1.44x | -4.80x |
| P/B Ratio | 0.72x | 0.57x | 0.14x | 0.46x | 0.61x | 0.69x |
| P/S Ratio | 0.21x | 0.24x | 0.05x | 0.21x | 1.28x | 2.36x |
| Profitability | ||||||
| Gross Margin | 69.0% | 75.3% | 62.0% | 52.0% | 44.5% | 70.0% |
| Operating Margin | -11.8% | -2.4% | -15.9% | -113.7% | -89.7% | -76.5% |
| Net Margin | -20.4% | -24.3% | -15.9% | -112.5% | -88.8% | -49.3% |
| EBITDA Margin | -7.0% | 2.2% | -3.0% | -28.9% | -44.2% | -44.2% |
| Liquidity | ||||||
| Current Ratio | 1.26x | 0.99x | 1.06x | 0.93x | 0.96x | 2.62x |
| Quick Ratio | 1.07x | 0.80x | 0.88x | 0.76x | 0.81x | 2.27x |
| Leverage | ||||||
| Debt/Equity | 1.21x | 0.59x | 0.77x | 0.41x | 0.23x | 0.02x |
YoY = year-over-year change. Source: FMP..